Thursday, May 23, 2019 10:15:06 AM
volume is sub - anemic... 7 minutes out of the first 40 minutes had 'at least one trade' take place...
Thats actually not a bad thing from the aspect of, at least those that own, are for the better part, currently holding on..
disclaimer: looking for that 'base' to develop before I start to nibble... (22 cents pre=split now).. own none
and on a side note: know 3 people now that have had joint replacements develop a nasty infection requiring the joints removal in 2 cases, the 3rd individual passed away from a combination of complications involving an infection. The latest one just had his joint removed, the infection 'cleaned out' and on a heavy anti-bio routine... Looking at 4-6 months before a replacement will be considered... So yeah, there is a lot of value in this one, especially since they have some experience thru the expanded access program the FDA is now allowing...
PS: any feedback on when the new board will be 'authorized'??
Thats actually not a bad thing from the aspect of, at least those that own, are for the better part, currently holding on..
disclaimer: looking for that 'base' to develop before I start to nibble... (22 cents pre=split now).. own none
and on a side note: know 3 people now that have had joint replacements develop a nasty infection requiring the joints removal in 2 cases, the 3rd individual passed away from a combination of complications involving an infection. The latest one just had his joint removed, the infection 'cleaned out' and on a heavy anti-bio routine... Looking at 4-6 months before a replacement will be considered... So yeah, there is a lot of value in this one, especially since they have some experience thru the expanded access program the FDA is now allowing...
PS: any feedback on when the new board will be 'authorized'??
Recent ARMP News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 08:16:34 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/25/2026 08:18:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:11:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/19/2026 11:10:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 11:48:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 11:46:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 01:18:25 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 01:18:19 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 01:17:29 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 01:17:22 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 01:16:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 01:15:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 01:14:59 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2026 12:10:46 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 01/26/2026 09:05:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2026 01:00:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/13/2026 12:10:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2025 10:17:48 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/01/2025 10:15:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 09:16:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 09:10:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/22/2025 03:15:43 PM
- Armata Pharmaceuticals to Present Late-Breaking Clinical Data highlighting its Staphylococcus aureus Bacteriophage Cocktail, AP-SA02, at IDWeek 2025™ • PR Newswire (US) • 10/14/2025 11:00:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/13/2025 09:16:56 PM
